GlassScriptPhysician profile
Katherine E Betcher
NPI 1164862033
$1,524.25
in general payments reported to CMS, 2019-2025
20 companies · $65.50 in 2025
The $65.50 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $25.70 · 2021: $56.74 · 2022: $158 · 2023: $462 · 2024: $484 · 2025: $65.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.70 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $304.78 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $239.07 | 2019-2023 | Lo Loestrin Fe |
| Medical Device Business Services, INC. | $178.46 | 2024 | Ethicon |
| Intuitive Surgical, INC. | $119.51 | 2019 | |
| Minerva Surgical, INC | $99.44 | 2022 | |
| Astellas Pharma US INC | $92.47 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $92.46 | 2023-2024 | Acessa Provu System, Novasure, Aptima |
| Aspira Women'S Health INC | $82.79 | 2024 | Ova1 |
| Pfizer INC. | $72.14 | 2023-2025 | |
| Organon LLC | $64.20 | 2022-2024 | Nexplanon |
| Meditrina | $29.78 | 2023 | |
| Myriad Women'S Health, INC. | $25.28 | 2023 | Myrisk |
| Daiichi Sankyo INC. | $24.05 | 2024 | Injectafer |
| Exeltis, USA INC. | $17.96 | 2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $15.88 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.79 | 2019 | |
| Coopersurgical, INC. | $15.38 | 2023 | Paragard T 380a |
| Conmed Corporation | $12.30 | 2019 | |
| Myovant Sciences INC. | $11.33 | 2021 | |
| Therapeuticsmd, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Betcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.